guaifenesin 400mg and dextromethorphan hbr 20mg · Tablet

What changed in the last 90 days

Every detected change for guaifenesin 400mg and dextromethorphan hbr 20mg, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Uncompetitive N-methyl-D-aspartate Receptor Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• acetaminohpen, dextromethorphan hydrobromide· 1 maker
• acetaminophen 325 mg and dextromethorphan hbr 10 mg oral liquid day time kids· 1 maker
• acetaminophen 325 mg dextromethorphan hbr 10 mg phenylephrine hci 5 mg· 1 maker
• acetaminophen 325 mg dextromethorphan hbr 15 mg doxylamine succinate 6.25 mg· 1 maker
• acetaminophen 325 mg, dextromethorphan hbr 15 mg, doxylamine succinate 6.25 mg· 1 maker
• acetaminophen 650 mg, dextromethorphan hbr 20 mg, guaifenesin 400 mg, phenylephrine hcl 10 mg· 1 maker
• acetaminophen chlorpheniramine maleate dextromethorphan hydrobromide phenylepherine hydrochloride· 1 maker
• acetaminophen dextromethorphan hbr doxylamine succinate phenylephrine hci· 1 maker
• acetaminophen dextromethorphan hbr guaifenesin, phenylephrine hcl· 1 maker
• acetaminophen-chlorpheniramine maleate-dextromethorphan hbr-guaifenesin-phenylephrine hcl· 1 maker
• acetaminophen-dextromethorphan hbr-phenylephrine hcl-chlorpheniramine maleate· 1 maker
• acetaminophen, chlorpheniramine malaeate, dextromethorphan hydrobromide, phenylephrine hydrochloride· 1 maker

Common questions

Is Guaifenesin 400mg and dextromethorphan hbr 20mg in shortage right now?

No. FDA does not currently list Guaifenesin 400mg and dextromethorphan hbr 20mg in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Guaifenesin 400mg and dextromethorphan hbr 20mg?

2 companies have marketed Guaifenesin 400mg and dextromethorphan hbr 20mg in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.